Copyright Reports & Markets. All rights reserved.

Global Bone Morphogenetic Protein (BMP) 2 Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Bone Morphogenetic Protein (BMP) 2 Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Bone Morphogenetic Protein (BMP) 2 Consumption 2014-2024
        • 2.1.2 Bone Morphogenetic Protein (BMP) 2 Consumption CAGR by Region
      • 2.2 Bone Morphogenetic Protein (BMP) 2 Segment by Type
        • 2.2.1 Sponge
        • 2.2.2 Gel
      • 2.3 Bone Morphogenetic Protein (BMP) 2 Consumption by Type
        • 2.3.1 Global Bone Morphogenetic Protein (BMP) 2 Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Bone Morphogenetic Protein (BMP) 2 Sale Price by Type (2014-2019)
      • 2.4 Bone Morphogenetic Protein (BMP) 2 Segment by Application
        • 2.4.1 Spinal Fusion
        • 2.4.2 Trauma Surgery
        • 2.4.3 Oral Maxillofacial Surgery
        • 2.4.4 Reconstructive
      • 2.5 Bone Morphogenetic Protein (BMP) 2 Consumption by Application
        • 2.5.1 Global Bone Morphogenetic Protein (BMP) 2 Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Bone Morphogenetic Protein (BMP) 2 Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Bone Morphogenetic Protein (BMP) 2 Sale Price by Application (2014-2019)

      3 Global Bone Morphogenetic Protein (BMP) 2 by Players

      • 3.1 Global Bone Morphogenetic Protein (BMP) 2 Sales Market Share by Players
        • 3.1.1 Global Bone Morphogenetic Protein (BMP) 2 Sales by Players (2017-2019)
        • 3.1.2 Global Bone Morphogenetic Protein (BMP) 2 Sales Market Share by Players (2017-2019)
      • 3.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Players
        • 3.2.1 Global Bone Morphogenetic Protein (BMP) 2 Revenue by Players (2017-2019)
        • 3.2.2 Global Bone Morphogenetic Protein (BMP) 2 Revenue Market Share by Players (2017-2019)
      • 3.3 Global Bone Morphogenetic Protein (BMP) 2 Sale Price by Players
      • 3.4 Global Bone Morphogenetic Protein (BMP) 2 Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Bone Morphogenetic Protein (BMP) 2 Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Bone Morphogenetic Protein (BMP) 2 Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Bone Morphogenetic Protein (BMP) 2 by Regions

      • 4.1 Bone Morphogenetic Protein (BMP) 2 by Regions
        • 4.1.1 Global Bone Morphogenetic Protein (BMP) 2 Consumption by Regions
        • 4.1.2 Global Bone Morphogenetic Protein (BMP) 2 Value by Regions
      • 4.2 Americas Bone Morphogenetic Protein (BMP) 2 Consumption Growth
      • 4.3 APAC Bone Morphogenetic Protein (BMP) 2 Consumption Growth
      • 4.4 Europe Bone Morphogenetic Protein (BMP) 2 Consumption Growth
      • 4.5 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption Growth

      5 Americas

      • 5.1 Americas Bone Morphogenetic Protein (BMP) 2 Consumption by Countries
        • 5.1.1 Americas Bone Morphogenetic Protein (BMP) 2 Consumption by Countries (2014-2019)
        • 5.1.2 Americas Bone Morphogenetic Protein (BMP) 2 Value by Countries (2014-2019)
      • 5.2 Americas Bone Morphogenetic Protein (BMP) 2 Consumption by Type
      • 5.3 Americas Bone Morphogenetic Protein (BMP) 2 Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Bone Morphogenetic Protein (BMP) 2 Consumption by Countries
        • 6.1.1 APAC Bone Morphogenetic Protein (BMP) 2 Consumption by Countries (2014-2019)
        • 6.1.2 APAC Bone Morphogenetic Protein (BMP) 2 Value by Countries (2014-2019)
      • 6.2 APAC Bone Morphogenetic Protein (BMP) 2 Consumption by Type
      • 6.3 APAC Bone Morphogenetic Protein (BMP) 2 Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Bone Morphogenetic Protein (BMP) 2 by Countries
        • 7.1.1 Europe Bone Morphogenetic Protein (BMP) 2 Consumption by Countries (2014-2019)
        • 7.1.2 Europe Bone Morphogenetic Protein (BMP) 2 Value by Countries (2014-2019)
      • 7.2 Europe Bone Morphogenetic Protein (BMP) 2 Consumption by Type
      • 7.3 Europe Bone Morphogenetic Protein (BMP) 2 Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 by Countries
        • 8.1.1 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption by Type
      • 8.3 Middle East & Africa Bone Morphogenetic Protein (BMP) 2 Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Bone Morphogenetic Protein (BMP) 2 Distributors
      • 10.3 Bone Morphogenetic Protein (BMP) 2 Customer

      11 Global Bone Morphogenetic Protein (BMP) 2 Market Forecast

      • 11.1 Global Bone Morphogenetic Protein (BMP) 2 Consumption Forecast (2019-2024)
      • 11.2 Global Bone Morphogenetic Protein (BMP) 2 Forecast by Regions
        • 11.2.1 Global Bone Morphogenetic Protein (BMP) 2 Forecast by Regions (2019-2024)
        • 11.2.2 Global Bone Morphogenetic Protein (BMP) 2 Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Bone Morphogenetic Protein (BMP) 2 Forecast by Type
      • 11.8 Global Bone Morphogenetic Protein (BMP) 2 Forecast by Application

      12 Key Players Analysis

      • 12.1 Medtronic
        • 12.1.1 Company Details
        • 12.1.2 Bone Morphogenetic Protein (BMP) 2 Product Offered
        • 12.1.3 Medtronic Bone Morphogenetic Protein (BMP) 2 Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Medtronic News
      • 12.2 Cellumed
        • 12.2.1 Company Details
        • 12.2.2 Bone Morphogenetic Protein (BMP) 2 Product Offered
        • 12.2.3 Cellumed Bone Morphogenetic Protein (BMP) 2 Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Cellumed News

      ...

        13 Research Findings and Conclusion

        Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductive—one of the three main categories of bone grafts—and play an active role in bone formation and maintenance.
        The classification of Bone Morphogenetic Protein (BMP) 2 includes sponge and gel types, and the proportion of sponge in 2016 is about 99%, and the proportion will be in decreasing trend from 2017 to 2022.
        Bone Morphogenetic Protein (BMP) 2 is widely used in spinal fusion, trauma surgery, oral maxillofacial surgery and reconstructive. The most proportion of Bone Morphogenetic Protein (BMP) 2 is used in spinal fusion, and the consumption proportion is about 62% in 2016.
        North America is the largest consumption place, with a consumption market share nearly 70% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
        Market competition is concentrated. Medtronic and Cellumed are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

        According to this study, over the next five years the Bone Morphogenetic Protein (BMP) 2 market will register a 2.0% CAGR in terms of revenue, the global market size will reach US$ 430 million by 2024, from US$ 390 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Bone Morphogenetic Protein (BMP) 2 business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares, and growth opportunities of Bone Morphogenetic Protein (BMP) 2 market by product type, application, key manufacturers and key regions and countries.

        This study considers the Bone Morphogenetic Protein (BMP) 2 value and volume generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
        Sponge
        Gel
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
        Spinal Fusion
        Trauma Surgery
        Oral Maxillofacial Surgery
        Reconstructive

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        Medtronic
        Cellumed
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global Bone Morphogenetic Protein (BMP) 2 consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of Bone Morphogenetic Protein (BMP) 2 market by identifying its various subsegments.
        Focuses on the key global Bone Morphogenetic Protein (BMP) 2 manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the Bone Morphogenetic Protein (BMP) 2 with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the consumption of Bone Morphogenetic Protein (BMP) 2 submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now